Smoothing the Road: Improving Heart Failure Awareness Among Clinicians and Patients скачать в хорошем качестве

Smoothing the Road: Improving Heart Failure Awareness Among Clinicians and Patients

Heart failure (HF) is among the most devastating diseases in cardiology. Based on statistics from the Heart Failure Society of America (HFSA), HF contributed to 425,147 deaths in the US in 2022, accounting for 45% of all cardiovascular mortality. Roughly 6.7 million Americans older than 20 years have HF – this number is expected to reach 8.7 million by 2030, 10.3 million in 2040, and 11.4 million by 2050.1 These statistics continue to rise despite a slew of available treatments and medications for HF and its associated risk factors. As more treatments are introduced and the overall prevalence of HF continues to increase, clinicians have largely turned to a lack of awareness of the options available to patients. Many drugs, including beta-blockers, mineralocorticoid receptor agonists, and SGLT2 inhibitors, have long been proven effective in both clinical trials and real-world use; however, patient access to and usage of these drugs remain low. Read the full article here: https://www.hcplive.com/view/smoothin... Key Timestamps 00:00:01 Intro 00:00:53 Muthiah Vaduganathan, MD, MPH, on reframing HF 00:02:25 Martha Gulati, MD, on getting medication to patients 00:08:19 Martha Gulati, MD, on the effects of the HFSA/ASPC joint statement 00:10:40 Viet Le, DMSc, PA-C, on past trials in HF 00:12:36 Viet Le, DMSc, PA-C, on advice for clinicians #cardiology #heartfailure